Cytosorbents press releases
WebCytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for the U.S. Clinical Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ … Webstingman49: CytoSorbents Press Release CytoSorb highlighted in NY Times' "Coronavirus Drug and Treatment Tracker" CytoSorbents Corporation (NASDAQ:CTSO)...
Cytosorbents press releases
Did you know?
WebMar 14, 2024 · PRINCETON, N.J., March 14, 2024 (GLOBE NEWSWIRE) — CytoSorbents Corporation(NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced today that it does not have any direct financial … WebAug 2, 2024 · CytoSorb ® actively reduces circulating cytokines, toxins, and other substances in blood that feed and perpetuate uncontrolled inflammation in a diverse set of medical emergencies such as sepsis, infection, trauma, cardiac surgery, and liver failure.
WebMar 8, 2024 · CytoSorbents Reports Fourth Quarter and Full Year 2024 Results and Provides 2024 Outlook 2024 total revenue was $43.2 million, including product sales of …
WebCytoSorbents’ blood purification technologies are based on advanced, biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and … WebPR Newswire. There is no web site at this address. Please contact us for assistance.
WebJul 22, 2024 · MONMOUTH JUNCTION, N.J., July 22, 2024 /PRNewswire/ -- CytoSorbents Corporation (Nasdaq: CTSO) (the "Company"), a critical care immunotherapy leader commercializing its CytoSorb® blood...
WebMar 22, 2024 · PRINCETON, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation CTSO, a leader in the treatment of life-threatening conditions in the intensive … grand mesa 2 footprintWebCytoSorbents Reports Fourth Quarter and Full Year 2024 Results. Pivotal U.S. and Canada STAR-T Trial enrollment passes halfway mark. Positive sales momentum from Q4 2024 continues in Q1 2024 to ... chinese furniture singapore rosewoodWebApr 11, 2024 · A high-level overview of Cytosorbents Corporation (CTSO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. grand mere state park campingWebCytoSorb ® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed in … chinese furniture and decorWebOct 14, 2024 · This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. chinese furniture store folsomWebMar 7, 2024 · CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood purification. Its lead product, CytoSorb ®, is... chinese furniture store markhamWebPRINCETON, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive … grand mesa arts cedaredge